Shrunken pore syndrome in relation to morbidity and mortality in the population-based Malmö Diet and Cancer cohort: a generalized propensity score approach

TL;DR

This study examines the prevalence and health impacts of Shrunken Pore Syndrome in a population-based cohort, finding a strong link to increased mortality.

Contribution

The study introduces a generalized propensity score approach to analyze Shrunken Pore Syndrome's association with health outcomes.

Findings

SPS was detected in 8.0% of the study population.

Individuals with SPS had a 60% higher risk of all-cause mortality.

The association with kidney disease seems to stem from low eGFRCYS rather than the eGFRCYS/eGFRCR ratio.

Abstract

Glomerular filtration rate (GFR) is used for evaluating kidney function. Creatinine and cystatin C levels are the two endogenous substances used to estimate GFR (eGFRCR and eGFRCYS). The agreement between these two is reflected by the eGFRCYS/eGFRCR ratio. An eGFRCYS/eGFRCR ratio <0.70 has been strongly associated with mortality and morbidity. An explanation is a selective decrease in the filtration of substances of different masses, and this condition is referred to as “Shrunken pore syndrome” (SPS). We aim to investigate the prevalence of SPS and its association with morbidity and mortality in a well-characterized population-based cohort.

The study population consisted of 5,061 individuals from the Malmö Diet and Cancer cardiovascular cohort (MDC-CC) with baseline examinations between 1991 and 1994 and a median follow-up of 25.3 years (IQR = 5.7). The eGFRCYS/eGFRCR ratio was categorized into four groups and used to estimate a generalized propensity score for SPS to adjust for confounding factors. Individuals were matched to create a quartet (one from each eGFRCYS/eGFRCR ratio category) with similar scores. We related the eGFRCYS/eGFRCR ratio to all-cause mortality, incident cardiovascular disease, incident kidney disease, and incident diabetes using Cox proportional hazards models with shared frailty.

SPS was detected in 405 individuals (8.0%). The hazard ratio (HR) for all-cause mortality was 1.6 [95% confidence interval (CI) 1.3–2.0] when comparing individuals with SPS to the reference group (eGFRCYS/eGFRCR ratio ≥ 1.0). For incident kidney disease, the association seems to stem from a low eGFRCYS rather than the eGFRCYS/eGFRCR ratio. For the other two outcomes, robust and statistically significant associations could not be found.

SPS was prevalent among middle-aged, generally healthy, individuals and led to markedly higher mortality during follow-up.

Figures